Chemotherapy regimens used in the study patients at the first and second mobilization attempts
Case . | Chemotherapy regimen . |
|---|---|
| 1-8 | IFO-VNB |
| 9-12 | DHAP |
| 13 | DT-PACE |
| 14-16 | FLAG-Ida |
Case . | Chemotherapy regimen . |
|---|---|
| 1-8 | IFO-VNB |
| 9-12 | DHAP |
| 13 | DT-PACE |
| 14-16 | FLAG-Ida |
IFO-VNB is ifosfamide (3 g/m2, intravenously [IV], days 1-4) and vinorelbine (25 mg/m2, IV, days 1 and 5).
DHAP is cisplatin (CDDP [cisplatin], 100 mg/m2, continuous IV infusion, day 1), cytarabine (ara-C, 2 g/m2, IV, every 12 hours, day 2), and dexamethasone (40 mg, IV, day 1-4).
DT-PACE is dexamethasone (40 mg, IV, day 1-4), thalidomide (100 mg, by mouth, CDDP (10 mg/m2, IV, day 1-4), cyclophosphamide (400 mg/m2, IV, day 1-4), doxorubicin (10 mg/m2, IV, day 1-4), and etoposide (40 mg/m2, IV, day 1-4).
FLAG-Ida is fludarabine (30 mg/m2, IV, day 1-5), ara-C (2 g/m2, IV, day 1-5), rhG-CSF (200 μg, subcutaneously, day 0-5), and idarubicin (10 mg/m2, IV, day 1-3).